Quick Answer
Ernexa Therapeutics Inc. reported Total Revenue of $582.0 thousand for fiscal year 2024.
Ernexa Therapeutics Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $582.0K | +755.9% |
| 2023 | $68.0K | — |
| 2022 | $0.00 | -100.0% |
| 2020 | $5.80M | -70.7% |
| 2019 | $19.81M | -15.1% |
| 2018 | $23.34M | +9.7% |
| 2017 | $21.27M | -4.7% |
| 2016 | $22.31M | -9.0% |
| 2015 | $24.52M | -5.9% |
| 2014 | $26.05M | +9.7% |
| 2013 | $23.75M | -1.3% |
| 2012 | $24.06M | +0.8% |
| 2011 | $23.87M | -5.7% |
| 2010 | $25.31M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $487.0K | +854.9% | +936.2% |
| June 30, 2024 | $47.0K | — | +0.0% |
| March 31, 2024 | $47.0K | — | -7.8% |
| September 30, 2023 | $51.0K | — | — |
| March 31, 2023 | $0.00 | — | — |
| September 30, 2022 | $0.00 | — | -100.0% |
| September 30, 2020 | $1.48M | -67.8% | +95.9% |
| June 30, 2020 | $754.0K | -85.6% | -68.5% |
- Ernexa Therapeutics Inc. showed an increase of +755.9% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2024 period, Ernexa Therapeutics Inc.’s total revenue has declined by 97.7% (from $25.31 million to $582.0 thousand).
- The most recent figure is from Ernexa Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: